Elucidating zerumbone’s low-efficacy agonism at the μ-opioid receptor via molecular dynamics simulation and Markov state modeling
Journal of Computer-Aided Molecular Design · 2025
DOI: 10.1007/s10822-025-00677-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Computer-Aided Molecular Design, 2025. Verfasst von Wan Mardhiyana Wan Ayub und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science and Technology, Universiti Sains Islam Malaysia, 71800, Nilai, Negeri Sembilan, Malaysia. Hauptthemen laut MEDLINE: Receptors, Opioid, mu, Sesquiterpenes, Analgesics, Opioid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Universiti Sains Islam Malaysia.
Abstract (Originalsprache)
Zerumbone is a natural sesquiterpene compound from Zingiber zerumbet plant. While it significantly exhibits analgesic properties through the μ-opioid receptor (μOR) found in animal models, its precise molecular mechanism at the receptor level remains poorly investigated. The present work involves 1-µs molecular dynamics (MD) simulations, MM/PBSA binding-free energy analyses, principal component analysis (PCA) as well as Markov state modeling (MSM) to address how the dynamic basis of zerumbone-μOR interactions compared to morphine, which is a known full agonist. MD trajectories reported greater receptor backbone fluctuations, improved loop mobility, reduced stable hydrogen bonds, and moderate receptor compaction in the zerumbone-bound state in contrast to morphine. MM/PBSA calculations indicated similar total binding affinity and the driven for zerumbone affinity was primarily hydrophobic interaction. PCA recognized notable intermediate conformational substates that were stabilized by zerumbone. In the interim, highly stabilized intermediate-activation macrostate with high-kinetic barriers (~ 8-16 k_BT) and millisecond-scale residency was also revealed through MSM analysis. In agreement with analgesic activities reported previously, these computational insights identify zerumbone as a low-efficacy partial agonist, providing comprehensive molecular explanation to its analgesic profile to serve as a source of safer and more opioid-like drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Science and Technology, Universiti Sains Islam Malaysia, 71800, Nilai, Negeri Sembilan, Malaysia.
- Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia, 71800, Nilai, Negeri Sembilan, Malaysia.
- Curtin Medical School, Faculty of Health Sciences, Curtin University, Bentley, Australia.
- Faculty of Science and Technology, Universiti Sains Islam Malaysia, 71800, Nilai, Negeri Sembilan, Malaysia. arifjamali@usim.edu.my.
Förderung
- Universiti Sains Islam Malaysia
Zitieren
APA
Ayub, W. M. W., Marjohan, N. A., Khalid, M. H., Perimal, E. K., & Jamali, M. A. M. (2025). Elucidating zerumbone’s low-efficacy agonism at the μ-opioid receptor via molecular dynamics simulation and Markov state modeling. Journal of Computer-Aided Molecular Design. https://doi.org/10.1007/s10822-025-00677-2
Vancouver
Ayub WMW, Marjohan NA, Khalid MH, Perimal EK, Jamali MAM. Elucidating zerumbone’s low-efficacy agonism at the μ-opioid receptor via molecular dynamics simulation and Markov state modeling. Journal of Computer-Aided Molecular Design. 2025. doi:10.1007/s10822-025-00677-2
BibTeX
@article{Ayub2025,
author = {Ayub, Wan Mardhiyana Wan and Marjohan, Nurul Amirah and Khalid, Mohamed Haneif and Perimal, Enoch Kumar and Jamali, Muhamad Arif Mohamad},
title = {Elucidating zerumbone’s low-efficacy agonism at the μ-opioid receptor via molecular dynamics simulation and Markov state modeling},
journal = {Journal of Computer-Aided Molecular Design},
year = {2025},
doi = {10.1007/s10822-025-00677-2}
}
EUVIMED